Cargando…
P1240: ANTI-PD-1-ANTIBODY (TISLELIZUMAB) COMBINED WITH DEACETYLASE INHIBITOR (CHIDAMIDE), LENALIDOMIDE AND ETOPOSIDE FOR THE TREATMENT OF REFRACTORY/RELAPSED EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA, NASAL
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431228/ http://dx.doi.org/10.1097/01.HS9.0000847824.69595.f0 |
| _version_ | 1784779994944241664 |
|---|---|
| author | Zhang, L. Liu, X. Wang, X. Chang, Y. Fu, X. Li, X. Li, L. Zhang, X. Yan, J. Nan, F. Zhu, L. Sun, Z. Yu, H. Guo, S. Sang, W. Wang, L. Zhang, M. |
| author_facet | Zhang, L. Liu, X. Wang, X. Chang, Y. Fu, X. Li, X. Li, L. Zhang, X. Yan, J. Nan, F. Zhu, L. Sun, Z. Yu, H. Guo, S. Sang, W. Wang, L. Zhang, M. |
| author_sort | Zhang, L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431228 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94312282022-08-31 P1240: ANTI-PD-1-ANTIBODY (TISLELIZUMAB) COMBINED WITH DEACETYLASE INHIBITOR (CHIDAMIDE), LENALIDOMIDE AND ETOPOSIDE FOR THE TREATMENT OF REFRACTORY/RELAPSED EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA, NASAL Zhang, L. Liu, X. Wang, X. Chang, Y. Fu, X. Li, X. Li, L. Zhang, X. Yan, J. Nan, F. Zhu, L. Sun, Z. Yu, H. Guo, S. Sang, W. Wang, L. Zhang, M. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431228/ http://dx.doi.org/10.1097/01.HS9.0000847824.69595.f0 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Zhang, L. Liu, X. Wang, X. Chang, Y. Fu, X. Li, X. Li, L. Zhang, X. Yan, J. Nan, F. Zhu, L. Sun, Z. Yu, H. Guo, S. Sang, W. Wang, L. Zhang, M. P1240: ANTI-PD-1-ANTIBODY (TISLELIZUMAB) COMBINED WITH DEACETYLASE INHIBITOR (CHIDAMIDE), LENALIDOMIDE AND ETOPOSIDE FOR THE TREATMENT OF REFRACTORY/RELAPSED EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA, NASAL |
| title | P1240: ANTI-PD-1-ANTIBODY (TISLELIZUMAB) COMBINED WITH DEACETYLASE INHIBITOR (CHIDAMIDE), LENALIDOMIDE AND ETOPOSIDE FOR THE TREATMENT OF REFRACTORY/RELAPSED EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA, NASAL |
| title_full | P1240: ANTI-PD-1-ANTIBODY (TISLELIZUMAB) COMBINED WITH DEACETYLASE INHIBITOR (CHIDAMIDE), LENALIDOMIDE AND ETOPOSIDE FOR THE TREATMENT OF REFRACTORY/RELAPSED EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA, NASAL |
| title_fullStr | P1240: ANTI-PD-1-ANTIBODY (TISLELIZUMAB) COMBINED WITH DEACETYLASE INHIBITOR (CHIDAMIDE), LENALIDOMIDE AND ETOPOSIDE FOR THE TREATMENT OF REFRACTORY/RELAPSED EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA, NASAL |
| title_full_unstemmed | P1240: ANTI-PD-1-ANTIBODY (TISLELIZUMAB) COMBINED WITH DEACETYLASE INHIBITOR (CHIDAMIDE), LENALIDOMIDE AND ETOPOSIDE FOR THE TREATMENT OF REFRACTORY/RELAPSED EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA, NASAL |
| title_short | P1240: ANTI-PD-1-ANTIBODY (TISLELIZUMAB) COMBINED WITH DEACETYLASE INHIBITOR (CHIDAMIDE), LENALIDOMIDE AND ETOPOSIDE FOR THE TREATMENT OF REFRACTORY/RELAPSED EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA, NASAL |
| title_sort | p1240: anti-pd-1-antibody (tislelizumab) combined with deacetylase inhibitor (chidamide), lenalidomide and etoposide for the treatment of refractory/relapsed extranodal natural killer/t cell lymphoma, nasal |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431228/ http://dx.doi.org/10.1097/01.HS9.0000847824.69595.f0 |
| work_keys_str_mv | AT zhangl p1240antipd1antibodytislelizumabcombinedwithdeacetylaseinhibitorchidamidelenalidomideandetoposideforthetreatmentofrefractoryrelapsedextranodalnaturalkillertcelllymphomanasal AT liux p1240antipd1antibodytislelizumabcombinedwithdeacetylaseinhibitorchidamidelenalidomideandetoposideforthetreatmentofrefractoryrelapsedextranodalnaturalkillertcelllymphomanasal AT wangx p1240antipd1antibodytislelizumabcombinedwithdeacetylaseinhibitorchidamidelenalidomideandetoposideforthetreatmentofrefractoryrelapsedextranodalnaturalkillertcelllymphomanasal AT changy p1240antipd1antibodytislelizumabcombinedwithdeacetylaseinhibitorchidamidelenalidomideandetoposideforthetreatmentofrefractoryrelapsedextranodalnaturalkillertcelllymphomanasal AT fux p1240antipd1antibodytislelizumabcombinedwithdeacetylaseinhibitorchidamidelenalidomideandetoposideforthetreatmentofrefractoryrelapsedextranodalnaturalkillertcelllymphomanasal AT lix p1240antipd1antibodytislelizumabcombinedwithdeacetylaseinhibitorchidamidelenalidomideandetoposideforthetreatmentofrefractoryrelapsedextranodalnaturalkillertcelllymphomanasal AT lil p1240antipd1antibodytislelizumabcombinedwithdeacetylaseinhibitorchidamidelenalidomideandetoposideforthetreatmentofrefractoryrelapsedextranodalnaturalkillertcelllymphomanasal AT zhangx p1240antipd1antibodytislelizumabcombinedwithdeacetylaseinhibitorchidamidelenalidomideandetoposideforthetreatmentofrefractoryrelapsedextranodalnaturalkillertcelllymphomanasal AT yanj p1240antipd1antibodytislelizumabcombinedwithdeacetylaseinhibitorchidamidelenalidomideandetoposideforthetreatmentofrefractoryrelapsedextranodalnaturalkillertcelllymphomanasal AT nanf p1240antipd1antibodytislelizumabcombinedwithdeacetylaseinhibitorchidamidelenalidomideandetoposideforthetreatmentofrefractoryrelapsedextranodalnaturalkillertcelllymphomanasal AT zhul p1240antipd1antibodytislelizumabcombinedwithdeacetylaseinhibitorchidamidelenalidomideandetoposideforthetreatmentofrefractoryrelapsedextranodalnaturalkillertcelllymphomanasal AT sunz p1240antipd1antibodytislelizumabcombinedwithdeacetylaseinhibitorchidamidelenalidomideandetoposideforthetreatmentofrefractoryrelapsedextranodalnaturalkillertcelllymphomanasal AT yuh p1240antipd1antibodytislelizumabcombinedwithdeacetylaseinhibitorchidamidelenalidomideandetoposideforthetreatmentofrefractoryrelapsedextranodalnaturalkillertcelllymphomanasal AT guos p1240antipd1antibodytislelizumabcombinedwithdeacetylaseinhibitorchidamidelenalidomideandetoposideforthetreatmentofrefractoryrelapsedextranodalnaturalkillertcelllymphomanasal AT sangw p1240antipd1antibodytislelizumabcombinedwithdeacetylaseinhibitorchidamidelenalidomideandetoposideforthetreatmentofrefractoryrelapsedextranodalnaturalkillertcelllymphomanasal AT wangl p1240antipd1antibodytislelizumabcombinedwithdeacetylaseinhibitorchidamidelenalidomideandetoposideforthetreatmentofrefractoryrelapsedextranodalnaturalkillertcelllymphomanasal AT zhangm p1240antipd1antibodytislelizumabcombinedwithdeacetylaseinhibitorchidamidelenalidomideandetoposideforthetreatmentofrefractoryrelapsedextranodalnaturalkillertcelllymphomanasal |